“mRNA技术不仅可以做预防性的疫苗,也可以用在肿瘤领域,康希诺在这块也做了一些工作。比如在过去几年,康希诺的上海子公司也一直在探索是否可以开发肿瘤疫苗,最近我们可能会有一些更深的研究。”3月8日,全国政协委员、康希诺生物首席科学官朱涛在接受澎湃新闻记者采访时介绍了上述情况。mRNA肿瘤疫苗并非传统意义上的预防性疫苗,而属于治疗性的手段,即通过诱导或增强机体针对肿瘤抗原的特异性主动免疫反应,从而...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.